Cart
sales@molnova.com
Vatanidipine
CAS No. 116308-55-5
Vatanidipine( —— )
Catalog No. M34043 CAS No. 116308-55-5
Vatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 730 | In Stock |
|
| 5MG | 454 | In Stock |
|
| 10MG | 621 | In Stock |
|
| 25MG | 941 | In Stock |
|
| 50MG | 1237 | In Stock |
|
| 100MG | 1628 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVatanidipine
-
NoteResearch use only, not for human use.
-
Brief DescriptionVatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.
-
DescriptionVatanidipine (AE0047) is a novel dihydropyridine (DHP)-type calcium channel blocker with slow-onset pharmacological actions.A slow-onset and long-lasting hypotensive action was observed in various experimental hypertensive models.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number116308-55-5
-
Formula Weight686.8
-
Molecular FormulaC41H42N4O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(OCCC1=CC=C(C=C1)N2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)(=O)C=5C(C(C(OC)=O)=C(C)NC5C)C6=CC(N(=O)=O)=CC=C6
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Procyanidin A1
Procyanidin A1 has antiallergic effects, it inhibits degranulation downstream of protein kinase C activation or Ca2+; influx from an internal store in RBL-2H3 cells.
-
GSK-7975A
A selective CRAC channel blocker that inhibits store-operated Ca(2+) entry with IC50 of 3.4 uM.
-
Calcium Channel anta...
Calcium Channel antagonist 2 is a calcium channel antagonist (IC50=5-20 μM) that can be used to study diseases due to Ca2+ channels like pain and diabetes.
